Healthcare & Life Sciences
Insilico Medicine
United Statesinsilico.com
Insilico Medicine is a series c plus startup based in Hong Kong. 3 investors tracked.
Activeseries-c-plus
series-c-plus
Stage
2014
Founded
3
Investors
About Insilico Medicine
Insilico Medicine is a company founded in 2014 headquartered in the United States. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 3 investors associated with the company.
Insilico Medicine develops and applies generative artificial intelligence and automation technologies to accelerate drug discovery, biomarker development, and disease modeling.
Explore Insilico Medicine's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.